Lasa Supergenerics Limited (BOM:540702)
7.74
+0.27 (3.61%)
At close: Jun 18, 2026
Lasa Supergenerics Revenue
In the fiscal year ending March 31, 2026, Lasa Supergenerics had annual revenue of 253.41M INR, down -82.82%. Lasa Supergenerics had revenue of -908.00K in the quarter ending March 31, 2026.
Revenue
253.41M
Revenue Growth
-82.82%
P/S Ratio
1.48
Revenue / Employee
3.84M
Employees
66
Market Cap
376.26M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 253.41M | -1.22B | -82.82% |
| Mar 31, 2025 | 1.47B | 430.26M | 41.20% |
| Mar 31, 2024 | 1.04B | -259.96M | -19.93% |
| Mar 31, 2023 | 1.30B | -66.97M | -4.88% |
| Mar 31, 2022 | 1.37B | -652.53M | -32.24% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Supha Pharmachem | 5.27B |
| Smruthi Organics | 1.02B |
| Tyche Industries | 628.56M |
| Vasundhara Rasayans | 357.23M |
| Link Pharma Chem | 274.32M |
| Crestchem | 266.14M |
| Krebs Biochemicals & Industries | 237.32M |
| Ishita Drugs and Industries | 146.60M |